Disease Awareness Ads, Not Ban On DTC, Is Best Marketing Path – Morris
A ban on direct-to-consumer advertising may have the unintended consequence of shifting marketing dollars into less transparent promotional vehicles, consultant Louis Morris said during a Pharmaceutical Marketing Partnerships Institute meeting in Philadelphia July 25
You may also be interested in...
An upcoming FDA draft guidance on fair balance in promotional materials could benefit manufacturers following a spate of warning letters from the agency's ad division citing the prominence of risk information
The Pharmaceutical Research & Manufacturers of America expects to have voluntary guidelines for direct-to-consumer advertising in place by August
Muraglitazar and abatacept are likely to be the first Bristol-Myers Squibb products significantly affected by the company's recent moratorium on direct-to-consumer advertising during a drug's first 12 months on the market